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1. INTRODUCTION 
Catecholamines through both a- and fl-adren- 
ergic receptors activate glycogenolysis and gluco- 
neogenesis in the rat liver [1-4]. There is consid- 
erable evidence that epinephrine activates glyco- 
genolysis through interaction with the al-adreno- 
ceptors in livers of adult rats. Glycogenolytic ac- 
tivation via the fl-receptor is negligible in these ani- 
mals. The characteristics of catecholamine activa- 
tion of these processes have been reported to be al- 
tered in adrenalectomized [5,6] and hypothyroid 
rats [7-9]. In these animals, a decrease in a-adren- 
ergic action concomitant with an increase in fl-ad- 
renergic action was observed [5,6,8,9]. It was fur- 
ther reported that the number of a-adrenergic 
receptors either remained unaltered [5,6], or de- 
creased [9] whereas fl-adrenergic receptor number 
was shown to increase [6-8]. The increase in fl-re- 
ceptor numbers was also associated with increases 
in the catecholamine-sensitive ad nylate cyclase 
activity [5,7,8]. Adrenalectomy as well as abnormal 
thyroid states often affect animals' food intake and 
normal weight-gain. We have reported that de- 
creases in hepatic glycogen phosphorylase ac- 
tivities (a form and total) as well as cAMP-depen- 
dent protein kinase elution pattern in adrenalecto- 
mized rats which lost weight after surgery, re- 
sembled those in briefly-fasted rats [5]. These 
observations prompted us to investigate the effects 
of fasting on the catecholamine-mediated regula- 
tion of hepatic glucose production. Here, we report 
that 20-24 h fasting resulted in no significant 
change in the number of binding sites for the mix- 
ed al-,a2-adrenergic antagonist [3H]dihydroergo- 
cryptine ([3H]DHE). However, there was a 25% de- 
crease in the density of al-adrenergic binding sites 
labeled with [3H]prazosin, and a 50% reduction in 
the number of binding sites for the selective a 2-ad- 
renergic antagonist [3H]yohimbine. Reciprocally, 
there was a marked increase (100%) in the density 
of the binding sites for the fl-antagonist [125I]iodo- 
cyanopindolol ([125I]CYP). In isolated hepatocytes, 
20-24 h fasting caused an increase in the catechol- 
amine-sensitive accumulation of cyclic AMP 
(cAMP) and in gluconeogenesis. 
2. EXPERIMENTAL 
[3H]DHE (21.9Ci/mmol), [3H]prazosin (18.0 
Ci/mmol), [3H]yohimbine (35Ci/mmol), and 
[125I]CYP (2200Ci/mmol) were from New En- 
gland Nuclear. The sources of other chemicals 
have been reported [3,10,11 ]. 
Methods previously described in detail were 
used with minor modifications to prepare plasma 
membrane from rat liver [111, to perform radio- 
ligand binding assays [3,11], to prepare hepato- 
cytes, to determine cyclic AMP contents and to es- 
timate gluconeogenesis [10]. Plasma membranes 
were isolated from livers of 220-270 g fed or 20- 
24 h fasted male Sprague-Dawley rats. 5'-Nucleo- 
tidase assay [12] showed similar specific activities 
of this enzyme in membranes prepared from fed or 
fasted rats. This indicates that fasting does not af- 
fect the constitution of the plasma membrane frac- 
tion used in radioligand binding experiments. In- 
cubation media and washing buffers used in the 
vacuum filtration procedure for the binding of 
[3H]DHE, [3H]prazosin, and [3Hlyohimbine 
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contained 50 mM Tris (pH 7.5), 0.8 mM ascorbic 
acid, and 3 mM catechol. (___)Propranol was pres- 
ent at 10/~M in the incubation medium. Binding of 
the fl-receptor ligand []25I]CYP was performed in 
[13] with some modifications. Incubations were 
performed at 25°C for 60 min in 50 mM Tris buff- 
er (pH 7.6), containing 150 mM NaCI, and 7 -  
15/tg plasma membrane protein. The filters were 
washed with 10mM Tris buffer (pH7.5), con- 
taining 150mM NaCI. For a-adrenergic ligand 
binding, specific binding is defined as the dif- 
ference between binding in the absence and pres- 
ence of 10/~M phentolamine. Specific binding of 
[125I]CYp is defined as the difference in binding in 
the absence and presence of 1/~M (_+) proprano- 
1ol. Throughout this report, 'binding' means ]aecif- 
ic binding of the radioligand as described above. 
Values for binding were averages of 4 determina- 
tions. Experiments were performed using at least 
two different plasma membranes preparations. 
Protein was determined as in [14] with bovine 
serum albumin as standard. 
3. RESULTS AND DISCUSSION 
3.1. Effects of fasting on the binding of a-adrenergic 
ligands and activation of hepatic glycogen phos- 
phorylase 
The effect of fasting on phenylephrine, an a-ad- 
renergic agonist, activation of glycogen phospho- 
rylase in isolated hepatocytes is shown in fig. 1. It is 
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Fig.l. Effects of increasing concentrations of phe- 
nylephrine on phosphorylase a activity in hepatocytes 
from fed (o) and 24 h fasted (.) rats. Data points are 
averages of 3 expt _ SEM. 
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Fig.2. Scatchard plots for the binding of [3H]prazosin 
(top), and [3H]DHE (bottom), to plasma membranes 
from fed (.), and fasted (,) rats. Data were calculated by 
normalizing protein concentrations to 20/~g/ml for 
[3H]prazosin binding, and 2mg/ml for [3H]DHE 
binding. 
seen that fasting caused about a 60% decrease in 
the maximally-stimulated phosphorylase activity, 
as well as a marked reduction in the sensitivity to- 
wards the tx-agonist as shown by a rightward shift 
in the dose-response curve. Fig.2A shows 
Scatchard plots [15] for the binding of [3H]pra- 
zosin, a selective al-adrenergic antagonist, o liver 
plasma membranes from fed and fasted rats. Val- 
ues for dissociation contents (KD) and the maximal 
number of binding sites (Bmax) derived from these 
plots are given in table 1. The binding parameters 
obtained for membranes from fed rats are com- 
parable to values in [9,16]. Fasting resulted in a 
398 
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Table 1 
Values for KD and Bma x derived from Scatchard plots for the binding of a- and fl-adrenergic 
radioligands to liver plasma membranes isolated from fed and 24 h fasted rats 
Ligand Fed rats Fasted rats 
K D (nM) Bmax n KD (nM) Bma x n 
[3H]prazosin 0.32___0.02 1468 _ 63 3 0.32_.+0.07 1080 __. 39 3 
[3H]DHE 9.0 _1.0 1640 __.204 3 10 __.3.0 1409 ---261 3 
[125I]CYP 0.09___0.02 15.6 _ 2.2 4 0.10___0.02 29.1___ 3.7 4 
[3H]Yohimbine 21.0 ±4.0 110 _ 17 4 21.1 ___1.9 65 _ 3 4 
Bmax-values are given in fmol/mg protein; n is the number of experiments 
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Fig.3. Scatchard plots for the binding oi" [125I]CYP to 
plasma membranes from fed (e), and fasted (,) rats. 
Data were calculated by normalizing protein 
concentrations to 25/tg/ml. 
25% reduction in the Bma x for the al-adrenergic 
antagonist prazosin. Scatchard plots derived from 
binding data of [3H]DHE are shown in fig.2B. The 
values for KD and Bmax are given in table 1. For 
this mixed a-receptor ligand, fasting caused about 
a 15% decrease in the maximal number of binding 
sites. This change however, is not statistically sig- 
nificant. These results are similar to those obtained 
for adrenalectomized and hypothyroid rats in 
which no change in Bmax for [3H]DHE [6], and a 
30% decrease in Bma x for [3H]prazosin [9] have 
been observed. 
Since catecholamine activation of rat hepatic 
glycogen phosphorylase is primarily al-receptor 
mediated [3,4,16], the reduced al-adrenergic 
ligand binding could at last in part be responsible 
for the decrease phenylephrine s nsitivity in hepa- 
tocytes from fasted rats. 
3.2. Effects of fasting on the fl-adrenergic system 
The new fl-adrenergic antagonist [125I]CYP was 
used for the identification and characterization f 
fl-adrenergic binding sites in the rat liver. This ra- 
dioligand has been used successfully [13] to identi- 
fy fl-adrenergic receptors in guinea pig lung and 
left ventricular membranes. We found [125I]CYP 
to bind to rat liver plasma membranes with great 
affinity. Specific binding was > 70% of total bind- 
ing. Binding of this radioligand was rapid and 
reached equilibrium within 15 min at 25°C. It was 
possible to dissociate 80% of the bound [125I]CYP 
from plasma membranes using propranolol within 
40min. fl-Adrenergic agonists and antagonists 
competed with []25I]CYp binding in a manner 
consistent with its binding to fl-adrenergic recep- 
tors. Binding of CYP was also stereospecific, with 
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Table 2 
Effect of epinephrine on epinephrine stimulation of 
cAMP accumulation i hepatocytes from fed and 24 h 
fasted rats 
Additions Fed Fasted 
(~tM) (nmol cAMP/g cell) 
Saline 557+ 14 781+20 
Epinephrine (5) 664 + 20 1006 + 24 
Epi (5) + yohimbine (0.1) 655 +20 972+_40 
Epi (5) + yohimbine (10) 646+- 10 938+20 
Epi (5) + propanolol (50) 588 +- 14 816 + 12 
Hepatocytes were incubated in the presence of b!ockers,. 
where designated, for 10 min. Epinephrine was then 
added and aliquots were taken 2 min later for cAMP de- 
terminations. Values taken from a typical experiment, 
are averages of 5 incubations each +_ SEM 
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Fig.4. [14C]Glucose production from [1-14C]lactate in
hepatocytes isolated from fed (o) and 24 h fasted (o) 
rats. Aliquots (l ml) of hepatocyte suspension (40 mg 
wet wt) were incubated with 5/~M phenoxybenzamine 
for 10 min. Epinephrine at concentrations i dicated and 
[l-14C]lactate (5 mM, final conc.) were then added to 
each flask and incubation was carried out for another 
30 min. Specific radioactivity of [1-12C]lactate was 
20 uCi/mmol. Data presented are averages of 3 
incubations +_ SEM. 
(-)-propranolol 2 orders of magnitude more po- 
tent that (+)propranolol in displacing the radio- 
ligand. Unlike the binding of [3 H]dihydroalpreno- 
lol and [125I]iodohydroxybenzylpindolol [6,7,17], 
binding of [125I]CYp was not affected by the c~-ad- 
renergic antagonist phentolamine atup to 0.1 mM. 
Fig.3 shows the binding of [125I]CYP to liver 
plasma membranes from fed and fasted rats. The 
binding parameters obtained are presented in 
table 1. Fasting for 24 h resulted in 100% increase 
in the number of B-adrenergic binding sites la- 
beled with [125I]CYP. Interestingly, this rate of in- 
crease in the fl-adrenergic binding sites is similar 
to the synthesis rate of fi-receptors in cultured 
human lung cells [18]. This increase in fi-receptor 
sites represents a functional increase with respect 
to fi-adrenergic action as shown by an enhanced 
epinephrine-sensitive cyclic AMP accumulation i
hepatocytes isolated from fasted rats (table 2). Epi- 
nephrine-mediated elevation of cAMP contents, in 
either fed or fasted rat hepatocytes, was completely 
blocked by the addition of propranolol, consistent 
with a p-adrenoreceptor mediated action. 
The increase in fl-receptor action induced by 
fasting was further demonstrated by its effect on 
epinephrine stimulation of gluconeogenesis in iso- 
lated hepatocytes, in the presence of a maximally 
effective concentration of an or-antagonist, phen- 
oxybenzamine. In the presence of the c~-blocker, 
epinephrine, at a wide range of concentrations, ex- 
erted no effect on the conversion of [l-14C]lactate 
to glucose in hepatocytes from fed rats (rigA). In 
contrast, there was a clear dose-dependent stimula- 
tion of [14C]glucose production by epinephrine 
(plus phenoxybenzamine) in cells from fasted rats. 
The addition of 10/~M (+_)-propranolol com- 
pletely inhibited the epinephrine action, at all con- 
centrations tested (not shown). These observations 
are consistent with an increase in fl-adrenergic ac- 
tion on gluconeogenesis in the livers of fasted rats. 
In light of a recent suggesting that c~2-adrenergic 
receptor action could inhibit fl-adrenergic activa- 
tion of adenylate cyclase in the rat liver [19], the 
effect of fasting on epinephrine-mediated cAMP 
increases may not therefore be viewed as changes 
in fl-receptor action alone. We therefore investig- 
ated the changes in ct2-adrenergic receptors in re- 
sponse to fasting, using [3H]yohimbine, a selective 
c~2-antagonist [20,21]. Fig.5 shows Scatchard plots 
for the binding of [3H]yohimbine. Binding para- 
400 
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Fig.5. Scatchard plots for the binding of [3H]yohimbine 
to plasma membranes from fed (o) and fasted (A) rats. 
Data were calculated by normalizing protein 
concentrations to 2 mg/ml. 
meters are shown in table 1. In comparison to the 
al-receptor subtype, fasting caused a more dra- 
matic reduction in this a2-1igand binding. A 50% 
reduction in the number of binding sites for [3H]- 
yohimbine was observed, after a 24 h fast. This de- 
clined further to 20% to the fed value after fasting 
for 72 h (not shown). In contrast o the effects of 
yohimbine described for other systems [22-24], 
addition of a wide range of concentrations of yo- 
himbine had no effect on epinephrine stimulation 
of cAMP accumulation i hepatocytes from either 
fed or fasted rats. Typical results are shown in 
table 2. These data indicate that in spite of the 
marked difference in yohimbine binding between 
fed and fasted rats, the a2-antagonist was equally 
ineffective in influencing fl-adrenergic action in 
either preparations. 
The changes in ct- and fl-adrenergic binding site 
densities reported here are consistent with a coor- 
dinated shift in the mechanism of hepatic glucose 
production from predominantly glycogenolytic n
the fed state to gluconeogenic n the fasted con- 
dition. The action of catecholamines in adult rat 
liver glycogenolysis clearly al-receptor medi- 
ated. Even in the fasted state when hepatic 
glycogen store is depleted, activation of glycogen 
phosphorylase, although with reduced sensitivity, 
is still largely via the a l-receptor. The type of ad- 
renergic action on hepatic gluconeogenesis i , 
however, less clear. Mechanisms from solely a-ad- 
renergic [1,25] to a mixed a- and fl-adrenergic 
[2,26] have been reported. It is rather clear, 
however, that regulations exerted by epinephrine 
on key regulatory enzymes in the gluconeogenic 
pathway, e.g., pyruvate kinase [27], and those reg- 
ulating fructose-2, 6-bisphosphate l vels [27] are 
predominantly fl-adrenergic. Although controls of 
pyruvate kinase [11,28,29] and pyruvate carboxyla- 
tion [29] via an a-adrenergic mechanism have been 
observed, the potencies of epinephrine on these 
enzyme systems are far less than those described 
for more typical hepatic a-adrenergic actions, 
namely, phosphorylase activation [2,30] and cal- 
cium mobilization [30]. Our results are consistent 
with an increased role for the fl-receptor in reg- 
ulating hepatic gluconeogenesis in the fasted state. 
Fasting selectively reduces a-adrenergic receptor 
densities in the rat liver. This coincides with a de- 
creased role of hepatic glycogenolysis n glucose 
production, a pathway normally activated pre- 
dominantly by the al-adrenergic receptor. The 
marked increase in fl-adrenergic binding site den- 
sity correlates well with increases in the fl-receptor- 
mediated stimulation of cAMP accumulation and 
gluconeogenesis in livers of fasted rats. In view of 
the uncertain function of the hepatic a2-adrenergic 
receptors, the physiological significance of the fast- 
ing-induced loss in this adrenergic receptor sub- 
type remains unclear. The resemblance among 
some of the effects of brief fasting, adrenalectomy 
[5], and abnormal thyroid states [7-9], on hepatic 
catecholamine r ceptors and actions may be for- 
tuitous. However, reduced food intake, for animals 
whose weight gains deviated markedly from nor- 
mal after treatment in particular, as part contribu- 
tor to these changes cannot be ruled out. 
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